Cardiff Oncology CRDF
NASDAQ CRDF
$0.93 -0.01 (-1.06%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cardiff Oncology (CRDF) Notes Payables (2020)

Updated

Cardiff Oncology (CRDF) reported Notes Payables of $305,000 for Q3 2020, up 331.2% from the prior quarter.

Analysis

Cardiff Oncology (CRDF) Notes Payables (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Cardiff Oncology 61.82 Mn 27.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 305,000.00
Jun 30, 2020 70,730.00
API Access

Cardiff Oncology Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=CRDF&period=max&api_key=YOUR_API_KEY